Drug therapy for Celiac Sprue
    108.
    发明授权
    Drug therapy for Celiac Sprue 失效
    腹腔注射药物治疗

    公开(公告)号:US07265093B2

    公开(公告)日:2007-09-04

    申请号:US10716846

    申请日:2003-11-18

    IPC分类号: A61K38/00

    摘要: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.

    摘要翻译: 将有效剂量的tTGase抑制剂用于腹膜炎或疱疹样皮炎患者减少毒性麸质寡肽的毒性作用,从而减弱或消除麸质的破坏作用。